Drug · DIN 02330695
ERAXIS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 25, 2010; first marketed January 25, 2010.
- Drug Identification Number (DIN)
- 02330695
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Anidulafungin J02AX06
- Class
- Human
- Record last updated
- June 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ANIDULAFUNGIN | 100 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 28, 2009: NOC 10452Supplement to a New Drug Submission (SNDS) · New presentation without solvent
Other DINs named ERAXIS
- DIN 02302160 · Cancelled Post Market